Adjunctive treatment with interferon alpha-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence.
Chen
Hung-Chiao
HC
Department of Ophthalmology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan.
Chang
Shu-Wen
SW
Huang
Shiu-Feng
SF
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000473:pathology / Q000601:surgery* / Q000821:virology*; D017024:Chemotherapy, Adjuvant; D003230:Conjunctival Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery* / Q000821:virology*; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D027383:Papillomaviridae / Q000302:isolation & purification*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins